Vagus nerve stimulation therapy in partial epilepsy: a review

Area of Science:

• Neurology
• Neurosurgery
• Medical Devices

Background:

• Epilepsy affects millions globally, with 20-30% developing drug-resistant forms.
• Medically refractory epilepsy poses significant challenges in patient management.
• Vagus nerve stimulation (VNS) emerged as a neuromodulatory treatment for refractory epilepsy.

Purpose of the Study:

• To review the literature on Vagus Nerve Stimulation (VNS) from 1988 to the present.
• To discuss the anatomy, physiology, mechanisms, and clinical applications of VNS.
• To evaluate the safety, tolerability, and effectiveness of VNS therapy.

Main Methods:

• Comprehensive literature review of studies on VNS for epilepsy.
• Analysis of anatomical and physiological aspects of vagus nerve function.
• Assessment of clinical outcomes, including seizure control and quality of life.

Main Results:

• VNS is an effective and well-tolerated adjunctive therapy for medically refractory partial-onset seizures in adults and children.
• Patients receiving VNS reported improvements in mood, alertness, memory, and overall well-being.
• The adverse effect profile of VNS differs from antiepileptic drugs, offering an alternative for patients with tolerability issues.

Conclusions:

• Vagus nerve stimulation remains a valuable treatment option for drug-resistant epilepsy.
• VNS demonstrates potential therapeutic applications beyond epilepsy.
• Continued research into VNS is warranted for various neurological conditions.